Company: RGNT
Filing Date: 2025-09-09
Form Type: 8-A12B
Source: 0001213900-25-086109
Chunk: 0

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-09
Form: 8-A12B
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF l934

REGENTIS BIOMATERIALS LTD.

(Exact name of Registrant as specified in its charter)</div>

| State of Israel         |     | Not Applicable     |
| (State of incorporation 
 or organization)        |     | -I.R.S. Employer   
 Identification No. |

| 60 Medinat Hayehudim                     
 Herzliya, Israel                         
 Tel: +972 (9) 960-1917                   |     |   4676652 |
| (Address of principal executive offices) |     | -Zip Code |

<div align='center'>Securities to be registered pursuant to Section 12(b) of the Act:</div>

| Title of each class           
 to be so registered           |     | Name of each exchange on which 
 each class is                  
 to be registered               |
| Ordinary Shares, no par value |     | NYSE American, LLC             |

If this form relates to the registration of a
class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), please
check the following box. ☒

If this form relates to the registration of a
class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), please
check the following box. ☐

If this form relates to the registration of a
class of securities concurrently with a Regulation A offering, check the following box. ☐

<div align='center'>Securities Act registration statement file number to which this form relates:

333-285692

Securities to be registered pursuant to Section 12(g) of the Act:

None

(Title of Class)</div>

Item 1. Description of Registrant’s Securities to be Registered.

Regentis Biomaterials Ltd. (the “Registrant”)
hereby incorporates by reference the description of its ordinary shares, no par value, to be registered hereunder, contained under the
heading “Description of Share Capital” in the Registrant’s Registration Statement on Form F-1 (File No. 333-285692